GlassScriptPhysician profile
Julie Park
NPI 1316084593
$6,904.00
in general payments reported to CMS, 2019-2025
27 companies · $1,509 in 2025
The $1,509 reported for 2025 was more than what 79% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $896 · 2020: $323 · 2021: $1,722 · 2022: $699 · 2023: $972 · 2024: $784 · 2025: $1,509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,265.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $1,584.71 | 2020-2022 | |
| Abbvie INC. | $656.50 | 2023-2025 | |
| Allergan, INC. | $605.45 | 2019-2022 | |
| Mentor Worldwide LLC | $465.91 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Avita Medical Americas, LLC | $342.53 | 2023-2025 | Recell, Permeaderm, Cohealyx |
| Kci USA, INC. | $324.68 | 2019-2020 | |
| Davol INC. | $294.54 | 2022-2025 | Phasix Mesh |
| Tela Bio, INC. | $291.34 | 2024 | Ovitex 2s |
| Integra Lifesciences Corporation | $255.43 | 2019-2025 | Integra, Primatrix, Surgimend |
| Motiva USA, LLC | $195.78 | 2025 | |
| Musculoskeletal Transplant Foundation INC. | $180.13 | 2023-2025 | |
| Axogen | $168.45 | 2019-2022 | |
| Kerecis Limited | $157.16 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Zimmer Biomet Holdings, INC. | $145.77 | 2019 | |
| Vioptix INC | $142.70 | 2020-2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $129.53 | 2023 | |
| Aroa Biosurgery Incorporated | $125.50 | 2024 | |
| Solventum Corporation | $110.05 | 2024-2025 | Prevena, V.A.C. Veraflo |
| Baxter Healthcare | $108.69 | 2019 | |
| Biocircuit Technologies INC | $105.62 | 2025 | Nerve Tape |
| Ethicon US, LLC | $100.33 | 2024 | Stratafix, Dermabond Prineo |
| Tepha INC | $92.93 | 2019 | |
| Stryker Corporation | $82.19 | 2025 | Dermacell |
| W. L. Gore & Associates, INC. | $75.98 | 2019 | |
| Medline Industries LP | $73.76 | 2020 | |
| Rti Surgical, INC | $67.29 | 2022 | |
| Organogenesis INC. | $21.05 | 2024 | Puraply Franchise |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.